In conclusion, IOX1 effectively downregulates the PD-L1 expression in cancer cells and even reverse the DOX-induced high PD-L1 expression, disrupting the PD-1/PD-L1 axis and restoring the proliferation and activity of T cells. The gene discussed is CD274; the disease is cancer.